Nuvation Bio Inc. (NUVB)

6.81USD +0.59% (+0.04)

Over 1M: +3.2%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

6.5 7
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 13.1M Q3 '25 — Operating Income: -56.4M Q4 '25 — Revenue: 41.9M Q4 '25 — Operating Income: -34M Q1 '26 — Revenue: 83.2M Q1 '26 — Operating Income: 3.9M Q2 '26 — Revenue: 31.7M Q2 '26 — Operating Income: -51M -30M 0 30M 60M 90M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 20.9%
OE margin -91.8%
Oper. margin -81.0%
Accruals -3.9%
EBITDA margin -79.7%
FCF margin -70.9%
OCF margin -70.9%
Profit margin -88.2%
ROA -20.1%
ROCE -20.9%
ROE -59.0%
Capex / sales —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

2.8
EV/Sales 11.7×
EV/OE -12.7×
P/C 3.6×
EV/GP 136.4×
FCF yield -5.0%
P/B 9.4×
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
RPO / sales 0.052×
RPO growth —
Segment HHI —

1 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 0.21
Cash / Debt 2.7×
Debt payback 0.0 yr
Quick ratio 8.1×
Cash runway 3.5 yr
Debt / Eq 0.96×
F-score 3.9 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales/sh Y/Y +831.2%
Sales Q/Q +555.6%
Shares change +27.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.